[{"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-113013000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-7005000.0,"ProceedsFromSaleOfProductiveAssets_2_Q2_USD":78764000.0,"LongTermDebtFairValue_0_Q2_USD":7935142000.0,"DeferredFinanceCostsNet_0_Q2_USD":64040000.0,"RestrictedCashAndCashEquivalents_0_Q2_USD":5962000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1_Q2_USD":185000.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":9370000.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":5291000.0,"DirectFinancingLeaseRevenue_2_Q2_USD":104925000.0,"DirectFinancingLeaseRevenue_1_Q2_USD":52489000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":140701000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":107919000.0,"TreasuryStockValue_0_Q2_USD":777000.0,"DividendsPayableCurrentAndNoncurrent_0_Q2_USD":143264000.0,"DividendsCommonStockCash_1_Q2_USD":143264000.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":915950000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":761700000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":496040000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q2_USD":1628360000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":128215000.0,"InterestPaid_2_Q2_USD":147502000.0,"NotesReceivableGross_0_Q2_USD":1339258000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":349000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":184000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":140352000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":107735000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":7200203000.0,"EquityMethodInvestments_0_Q2_USD":841098000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":524428000.0,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.27,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":1099000.0,"ProceedsFromSaleOfRealEstate_2_Q2_USD":79000000.0,"PaymentsToAcquireRealEstate_2_Q2_USD":2226302000.0,"PaymentsToAcquireLoansReceivable_2_Q2_USD":62064000.0,"PaymentsOfOrdinaryDividends_2_Q2_USD":279741000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-12373000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2_Q2_USD":-17097000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q2_USD":6175000.0,"NumberOfStatesInWhichEntityOperates_0_Q2_State":34.0,"NumberOfCountriesInWhichEntityOperates_0_Q2_Country":6.0,"NotesReceivableNet_0_Q2_USD":2131269000.0,"NetInvestmentInLease_0_Q2_USD":2078209000.0,"MortgageLoansOnRealEstateCommercialAndConsumerNet_0_Q2_USD":1339258000.0,"LoansHeldForSaleFairValueDisclosure_0_Q2_USD":1879511000.0,"GainsLossesOnSalesOfInvestmentRealEstate_2_Q2_USD":-1776000.0,"GainsLossesOnSalesOfInvestmentRealEstate_1_Q2_USD":-3101000.0,"GainLossOnDispositionOfRealEstateDiscontinuedOperations_2_Q2_USD":-1800000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":155000.0,"DirectFinancingLeaseUnguaranteedResidualAsset_0_Q2_USD":394195000.0,"DirectFinancingLeaseNetInvestmentInLease_0_Q2_USD":663828000.0,"DirectFinancingLeaseLeaseReceivable_0_Q2_USD":1853967000.0,"ContractWithCustomerLiability_0_Q2_USD":18638000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":-1087222000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":380924000.0,"BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_0_Q2_USD":2226302000.0,"BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_0_Q2_USD":134203000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":6438000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":1102000.0,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.54,"ReceivablesFairValueDisclosure_0_Q2_USD":40496000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":527781000.0,"NonoperatingIncomeExpense_2_Q2_USD":-21707000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-19771000.0,"ProfitLoss_1_Q2_USD":109652000.0,"ProfitLoss_2_Q2_USD":190809000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":169787000.0,"NetIncomeLoss_2_Q2_USD":190460000.0,"NetIncomeLoss_1_Q2_USD":109468000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":289066000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-2180280000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":803992000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":15448070000.0,"Liabilities_0_Q2_USD":8380793000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":8839000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":4829000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":199648000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":114481000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":65403000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":32018000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":0.36,"EarningsPerShareBasicAndDiluted_1_Q2_USD":0.21,"CostsAndExpenses_2_Q2_USD":364619000.0,"CostsAndExpenses_1_Q2_USD":183842000.0,"CommonStockValue_0_Q2_USD":529000.0,"CommonStockSharesOutstanding_0_Q2_shares":528641000.0,"CommonStockSharesIssued_0_Q2_shares":528641000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":374962000.0,"Assets_0_Q2_USD":15448070000.0,"AssetImpairmentCharges_2_Q2_USD":19006000.0,"Revenues_1_Q2_USD":291842000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":108105000.0,"Revenues_2_Q2_USD":585974000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"NonoperatingIncomeExpense_1_Q2_USD":6481000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":349000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":184000.0,"MinorityInterest_0_Q2_USD":106000.0,"LongTermDebt_0_Q2_USD":7795890000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":27674000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":7067277000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-9684000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":4291000.0,"OtherAssets_0_Q2_USD":296796000.0,"InterestAndOtherIncome_2_Q2_USD":83153000.0,"InterestAndOtherIncome_1_Q2_USD":44645000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":12216000.0,"AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_0_Q2_USD":443453000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":525530000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":528880000.0,"ShareBasedCompensation_2_Q2_USD":22228000.0,"PreferredStockValue_0_Q2_USD":null,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"InterestExpense_2_Q2_USD":161275000.0,"InterestExpense_1_Q2_USD":80376000.0,"DepreciationAndAmortization_2_Q2_USD":122384000.0,"DepreciationAndAmortization_1_Q2_USD":61463000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":7859930000.0,"CommonStockSharesAuthorized_0_Q2_shares":750000000.0,"StockholdersEquity_0_Q2_USD":7067171000.0,"ResidualValueOfLeasedAsset_0_Q2_USD":216300000.0,"Ticker":"MPW","CIK":"1287865","name":"MEDICAL PROPERTIES TRUST INC","OfficialName":"Medical Properties Trust Inc. common stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"11884019000.0","Country":"United States","Sector":"Consumer Services","Industry":"Real Estate Investment Trusts","Market":"NYSE","SP500":"nan","filed":"20200810"}]